Valneva SE (VALN) Form 6-K — Jun 1, 2026
Valneva SE announced that its senior management will participate in several investor conferences in the U.S. and Europe during June 2026. The company will hold a fireside chat at the Jefferies Global Healthcare Conference on June 3 and conduct investor meetings at the Oddo BHF Nextcap Forum and BNP Paribas SMID Cap Conference. Management plans to discuss Valneva’s commercial-stage vaccines and its pipeline, specifically highlighting LB6V, the Lyme disease vaccine candidate partnered with Pfizer.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.